Holen Sie sich die Stockscreener-App
8.11
3.18%
0.25
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$7.86
Offen:
$7.89
24-Stunden-Volumen:
65,642
Relative Volume:
0.66
Marktkapitalisierung:
$251.58M
Einnahmen:
$193.67M
Nettoeinkommen (Verlust:
$4.82M
KGV:
17.63
EPS:
0.46
Netto-Cashflow:
$15.53M
1W Leistung:
+0.25%
1M Leistung:
-3.11%
6M Leistung:
-23.35%
1J Leistung:
-9.28%
1-Tages-Spanne:
$7.80
$8.14
1-Wochen-Bereich:
$7.70
$8.14
52-Wochen-Spanne:
$7.15
$13.77
Zynex Inc Stock (ZYXI) Company Profile
Firmenname
Zynex Inc
Sektor
Branche
Telefon
(800)-495-6670
Adresse
9655 MAROON CIRCLE, ENGLEWOOD, CO
Vergleichen Sie ZYXI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| ZYXI | 9.30 | 0 | 0 | 0 | 0 | 0.00 |
| GOODO | 21.76 | 372.90M | 0 | 0 | 0 | 0.00 |
| PSNYW | 0.1388 | 293.13M | 2.07B | -1.42B | -1.37B | -0.1344 |
| MOBBW | 0.15 | 278.60M | 0 | 0 | 0 | 0.00 |
| SHMD | 2.54 | 103.78M | 0 | 0 | 0 | 0.00 |
| JUNE | 4.99 | 63.87M | 0 | 0 | 0 | 0.00 |
Zynex Inc Stock (ZYXI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-10-16 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-01-06 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-02-28 | Bestätigt | B. Riley Securities | Buy |
| 2021-07-16 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2021-03-09 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2021-02-26 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2021-01-29 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-01-28 | Herabstufung | Northland Capital | Outperform → Market Perform |
| 2020-09-14 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-09-09 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-07-29 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-07-20 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-13 | Herabstufung | B. Riley FBR | Buy → Neutral |
| 2020-07-10 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-06-16 | Herabstufung | Northland Capital | Outperform → Market Perform |
| 2020-05-19 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-04-01 | Eingeleitet | Northland Capital | Outperform |
| 2019-09-23 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Zynex Inc Aktie (ZYXI) Neueste Nachrichten
Zynex CEO Thomas Sandgaard sells shares worth $16,180 By Investing.com - Investing.com Canada
Zynex CEO Thomas Sandgaard sells shares worth $16,180 - Investing.com
PRESIDENT, CEO AND CHAIRMAN Sandgaard Thomas sold $16,180 worth of shares (2,000 units at $8.09), decreasing direct ownership by 0.01% to 14,603,662 units (SEC Form 4) - Quantisnow
Zynex, Inc Founder and CEO Thomas Sandgaard to participate in Benzinga's Pharma Companies vs. A Tough Macro Backdrop Free Webinar on August 3rd at 12:15 PM ET - Quantisnow
Insider Sale: Thomas Sandgaard Sells 10,000 Shares of Zynex Inc (ZYXI) - GuruFocus.com
Zynex CEO Thomas Sandgaard sells $89,280 in stock By Investing.com - Investing.com Canada
Zynex CEO Thomas Sandgaard sells $89,280 in stock - Investing.com
Building Momentum: Zynex Inc.'s (NASDAQ: ZYXI) Steady Rise in the Pain Management Market - openPR
Muscle Stimulation Devices Market Global Industry Growth - openPR
Insider Sale: President, CEO, and Chairman Thomas Sandgaard Sells Shares of Zynex Inc (ZYXI) - GuruFocus.com
Zynex CEO Thomas Sandgaard sells shares worth $51,080 - Investing.com India
Zynex CEO Thomas Sandgaard sells shares worth $51,080 By Investing.com - Investing.com UK
PRESIDENT, CEO AND CHAIRMAN Sandgaard Thomas sold $51,080 worth of shares (6,000 units at $8.51), decreasing direct ownership by 0.04% to 14,615,662 units (SEC Form 4) - Quantisnow
Trend Tracker for (ZYXI) - Stock Traders Daily
Zynex CFO Daniel Moorhead sells $85,900 in stock By Investing.com - Investing.com Australia
Insider Sale: CFO Daniel Moorhead Sells 10,000 Shares of Zynex I - GuruFocus.com
Zynex, Inc. (NASDAQ:ZYXI) CFO Daniel J. Moorhead Sells 10,000 Shares - MarketBeat
Zynex CFO Daniel Moorhead sells $85,900 in stock - Investing.com
Zynex, Inc. (NASDAQ:ZYXI) CEO Sells $17,260.00 in Stock - MarketBeat
Zynex CEO Thomas Sandgaard sells $52,740 in stock - Investing.com India
Insider Sale: Thomas Sandgaard Sells Shares of Zynex Inc (ZYXI) - GuruFocus.com
Zynex CEO Thomas Sandgaard sells $52,740 in stock By Investing.com - Investing.com Australia
Zynex's (NASDAQ:ZYXI) Soft Earnings Are Actually Better Than They Appear - Yahoo Finance
Zynex (ZYXI) Stock Forecast and Price Target 2024 - MarketBeat
Zynex Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Zynex (NASDAQ:ZYXI) Seems To Use Debt Quite Sensibly - Simply Wall St
Zynex, Inc. (NASDAQ:ZYXI) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Zynex reports steady Q3 growth, plans for future expansion - Investing.com India
Zynex Inc. (ZYXI) Tops Q3 Earnings Estimates - MSN
How To Trade (ZYXI) - Stock Traders Daily
Earnings call: Zynex reports steady Q3 growth, plans for future expansion By Investing.com - Investing.com South Africa
Zynex (NASDAQ:ZYXI) Posts Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Zynex (NASDAQ:ZYXI) Price Target Raised to $17.00 - MarketBeat
Zynex shares target increased, buy rating held on strong Q3 results - Investing.com
Zynex Inc (ZYXI) Q3 2024 Earnings Call Highlights: Navigating Gr - GuruFocus.com
Zynex Inc (ZYXI) Q3 2024 Earnings Call Highlights: Navigating Growth and Challenges - Yahoo Finance
Proactive financial news: fast, accessible, and actionable articles and videos for the global investment audience. - Proactive Investors USA
Zynex (NASDAQ:ZYXI) Updates FY 2024 Earnings Guidance - MarketBeat
Zynex sees pain management orders increase in Q3 following FDA approval - Proactive Investors UK
Zynex Reports Third Quarter 2024 Financial Results - PR Newswire
Sales, strategy, and saving lives: A conversation with Zynex CEO Thomas Sandgaard - Proactive Investors USA
Preview: Zynex's Earnings - Benzinga
Pain Management Devices Market Report 2024 and Company Benchmarking for Abbott, Medtronic, Zynex Medical, Boston Scientific and OMRON Healthcare - Yahoo Finance
Womens Health Rehabilitation Products Market to Witness Huge - openPR
Zynex, Inc. (NASD: ZYXI) Wins 2023 National Top Workplaces Award in the Manufacturing Industry Category - GuruFocus.com
Zynex Sets Third Quarter 2024 Earnings Call - Lelezard
Zynex Sets Third Quarter 2024 Earnings Call – Company Announcement - Financial Times
AQR Capital Management LLC Sells 67,148 Shares of Zynex, Inc. (NASDAQ:ZYXI) - MarketBeat
Finansavisen - Finansavisen
Millennium Management LLC Acquires 118,615 Shares of Zynex, Inc. (NASDAQ:ZYXI) - Defense World
Zynex, Inc.: 2025 Looks Like A Brighter Year (NASDAQ:ZYXI) - Seeking Alpha
Finanzdaten der Zynex Inc-Aktie (ZYXI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Zynex Inc-Aktie (ZYXI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Sandgaard Thomas | PRESIDENT, CEO AND CHAIRMAN |
Nov 12 '24 |
Sale |
9.24 |
2,000 |
18,480 |
14,607,662 |
| Sandgaard Thomas | PRESIDENT, CEO AND CHAIRMAN |
Nov 07 '24 |
Sale |
9.17 |
2,000 |
18,340 |
14,613,662 |
| Sandgaard Thomas | PRESIDENT, CEO AND CHAIRMAN |
Nov 11 '24 |
Sale |
9.09 |
2,000 |
18,180 |
14,609,662 |
| Sandgaard Thomas | PRESIDENT, CEO AND CHAIRMAN |
Nov 08 '24 |
Sale |
8.77 |
2,000 |
17,540 |
14,611,662 |
| Sandgaard Thomas | PRESIDENT, CEO AND CHAIRMAN |
Nov 13 '24 |
Sale |
8.37 |
2,000 |
16,740 |
14,605,662 |
| Sandgaard Thomas | PRESIDENT, CEO AND CHAIRMAN |
Nov 06 '24 |
Sale |
8.82 |
2,000 |
17,640 |
14,615,662 |
| Sandgaard Thomas | PRESIDENT, CEO AND CHAIRMAN |
Nov 04 '24 |
Sale |
8.67 |
2,000 |
17,340 |
14,619,350 |
| Sandgaard Thomas | PRESIDENT, CEO AND CHAIRMAN |
Nov 05 '24 |
Sale |
8.05 |
2,000 |
16,100 |
14,617,662 |
| MOORHEAD DANIEL J | CHIEF FINANCIAL OFFICER |
Nov 01 '24 |
Sale |
8.59 |
10,000 |
85,900 |
44,878 |
| Sandgaard Thomas | PRESIDENT, CEO AND CHAIRMAN |
Oct 30 '24 |
Sale |
8.92 |
2,000 |
17,840 |
14,625,350 |
0.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):